These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26307075)

  • 1. The lymphocyte-monocyte ratio in clinical practice.
    Balta S; Demırer Z; Aparci M; Yildirim AO; Ozturk C
    J Clin Pathol; 2016 Jan; 69(1):88-9. PubMed ID: 26307075
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
    Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
    J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma.
    Azuma T; Matayoshi Y; Odani K; Sato Y; Sato Y; Nagase Y; Oshi M
    Clin Genitourin Cancer; 2013 Sep; 11(3):337-41. PubMed ID: 23665132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASO Author Reflections: Significant Impact of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio on Survival Outcomes in Patients with Upper Tract Urothelial Carcinoma.
    Jan HC; Ou CH
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):563-564. PubMed ID: 30652225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical impact of peripheral lymphocyte counts for metastatic urothelial carcinoma patients treated with chemotherapy].
    Sekita N; Nishikawa R; Fujimura M; Takeuchi N; Ogino H; Shibata N; Omura S; Mikami K
    Hinyokika Kiyo; 2014 May; 60(5):215-9. PubMed ID: 24894856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer.
    Yakovlev P; Klyushin D
    Exp Oncol; 2018 Jun; 40(2):119-123. PubMed ID: 29949533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear size measurement for distinguishing urothelial carcinomas from reactive urothelium on tissue sections.
    Poropatich K; Yang JC; Goyal R; Parini V; Yang XJ
    Diagn Pathol; 2016 Jun; 11(1):57. PubMed ID: 27357719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma.
    Wiwanitit V
    Int Braz J Urol; 2015; 41(4):822. PubMed ID: 26401881
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutrophil-lymphocyte ratio evaluation in patients undergoing radical cystectomy.
    Agilli M; Aydin I; Aydin FN; Kurt YG; Cayci T
    Urol Oncol; 2014 Aug; 32(6):939. PubMed ID: 24880462
    [No Abstract]   [Full Text] [Related]  

  • 11. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
    Potretzke A; Hillman L; Wong K; Shi F; Brower R; Mai S; Cetnar JP; Abel EJ; Downs TM
    Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
    Fujita K; Tanigawa G; Imamura R; Nakagawa M; Hayashi T; Kishimoto N; Hosomi M; Yamaguchi S
    Int J Urol; 2013 Jun; 20(6):594-601. PubMed ID: 23131052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis.
    Tan D; Fu Y; Tong W; Li F
    Int J Surg; 2018 Jul; 55():128-138. PubMed ID: 29807167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer.
    Tsai YD; Wang CP; Chen CY; Lin LW; Hwang TZ; Lu LF; Hsu HF; Chung FM; Lee YJ; Houng JY
    Head Neck; 2014 Jul; 36(7):947-53. PubMed ID: 23733351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial Comment to Prognostic impact of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma.
    Papadopoulos GI
    Int J Urol; 2011 Jan; 18(1):48. PubMed ID: 21198936
    [No Abstract]   [Full Text] [Related]  

  • 17. Inverted (endophytic) noninvasive lesions and neoplasms of the urothelium: the Cinderella group has yet to be fully exploited.
    Montironi R; Cheng L; Lopez-Beltran A; Scarpelli M; Mazzucchelli R; Mikuz G; Kirkali Z; Montorsi F
    Eur Urol; 2011 Feb; 59(2):225-30. PubMed ID: 21122976
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.
    Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J
    Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio as a prognostic factor in upper tract urothelial cancer.
    Mirza M
    BJU Int; 2014 Sep; 114(3):316-7. PubMed ID: 25156498
    [No Abstract]   [Full Text] [Related]  

  • 20. What exactly are the cytoplasmic inclusions in metastatic urothelial carcinoma, and are they of diagnostic value?
    Riley ER; Paquette C; Leiman G
    Diagn Cytopathol; 2014 Sep; 42(9):816-8. PubMed ID: 23554301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.